Search research articles
Contact Us
Filters
Showing results (101-110 of 403) with videos related to
Page
of 41
Sort By:
Psychopharmacology
|
July 17, 2019
Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice
Aboagyewaah Oppong-Damoah, Kristen E Curry, Bruce E Blough, et al.
Psychopharmacology
|
September 21, 2012
Modification of the behavioral effects of morphine in rats by serotonin 5-HT₁A and 5-HT₂A receptor agonists: antinociception, drug discrimination, and locomotor activity
Jun-Xu Li, Aparna P Shah, Sunny K Patel, et al.
Psychopharmacology
|
October 13, 2005
Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats
Mary M Torregrossa, John E Folk, Kenner C Rice, et al.
Japanese Journal of Pharmacology
|
October 25, 2002
Behavioral effects of delta-opioid receptor agonists: potential antidepressants?
Daniel C Broom, Emily M Jutkiewicz, Kenner C Rice, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2006
The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol
Emily M Jutkiewicz, Michelle G Baladi, John E Folk, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 8, 2007
The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats
Emily M Jutkiewicz, Michelle G Baladi, John E Folk, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 15, 2005
Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats
Emily M Jutkiewicz, Sarah T Kaminsky, Kenner C Rice, et al.
Magnetic Resonance in Chemistry : MRC
|
December 13, 2012
Z and E rotamers of N-formyl-1-bromo-4-hydroxy-3-methoxymorphinan-6-one and their interconversion as studied by 1H/13C NMR spectroscopy and quantum chemical calculations
Agnieszka Sulima, Kejun Cheng, Arthur E Jacobson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2019
The Supplement Adulterant <i>β</i>-Methylphenethylamine Increases Blood Pressure by Acting at Peripheral Norepinephrine Transporters
Charles W Schindler, Eric B Thorndike, Kenner C Rice, et al.
Pharmacology, Biochemistry, and Behavior
|
May 8, 2023
Male and female C57BL/6 mice display drug-induced aversion and reward in the combined conditioned taste avoidance/conditioned place preference procedure
Hayley N Manke, Samuel S Nunn, Robert A Jones, et al.
Page
of 41
Search research articles
Search
Showing results (101-110 of 403) with videos related to
Sort By:
Page
of 41
Psychopharmacology
|
July 17, 2019
Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice
Aboagyewaah Oppong-Damoah, Kristen E Curry, Bruce E Blough, et al.
Psychopharmacology
|
September 21, 2012
Modification of the behavioral effects of morphine in rats by serotonin 5-HT₁A and 5-HT₂A receptor agonists: antinociception, drug discrimination, and locomotor activity
Jun-Xu Li, Aparna P Shah, Sunny K Patel, et al.
Psychopharmacology
|
October 13, 2005
Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats
Mary M Torregrossa, John E Folk, Kenner C Rice, et al.
Japanese Journal of Pharmacology
|
October 25, 2002
Behavioral effects of delta-opioid receptor agonists: potential antidepressants?
Daniel C Broom, Emily M Jutkiewicz, Kenner C Rice, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2006
The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol
Emily M Jutkiewicz, Michelle G Baladi, John E Folk, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 8, 2007
The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats
Emily M Jutkiewicz, Michelle G Baladi, John E Folk, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 15, 2005
Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats
Emily M Jutkiewicz, Sarah T Kaminsky, Kenner C Rice, et al.
Magnetic Resonance in Chemistry : MRC
|
December 13, 2012
Z and E rotamers of N-formyl-1-bromo-4-hydroxy-3-methoxymorphinan-6-one and their interconversion as studied by 1H/13C NMR spectroscopy and quantum chemical calculations
Agnieszka Sulima, Kejun Cheng, Arthur E Jacobson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2019
The Supplement Adulterant <i>β</i>-Methylphenethylamine Increases Blood Pressure by Acting at Peripheral Norepinephrine Transporters
Charles W Schindler, Eric B Thorndike, Kenner C Rice, et al.
Pharmacology, Biochemistry, and Behavior
|
May 8, 2023
Male and female C57BL/6 mice display drug-induced aversion and reward in the combined conditioned taste avoidance/conditioned place preference procedure
Hayley N Manke, Samuel S Nunn, Robert A Jones, et al.
Page
of 41